A Phase Ⅱ Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non–Small-Cell Lung Cancer: TORG2241 (UBE-Q)Shinji Nakamichi, Hiroaki Okamoto, Kaoru Kubota et al.|Clinical Lung Cancer|2023Cited by 6
Phase I/II trial of a low-emetic combination of S-1 plus docetaxel (DTX) for advanced non-small cell lung cancer (NSCLC).Kenichiro Komiyama, Yuka Uchida, Takashi Kasai et al.|Journal of Clinical Oncology|2011Cited by 0